Shoker Investment Counsel, Inc.
Source: SEC Form 13F · as of Mar 2026Shoker Investment Counsel, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $22.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$22.0M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 21,218 | $4.6M |
| JNJJOHNSON & JOHNSON | 18,168 | $4.4M |
| MRKMerck & Co., Inc. | 28,572 | $3.4M |
| GILDGILEAD SCIENCES, INC. | 21,050 | $2.9M |
| PFEPFIZER INC | 95,378 | $2.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,914 | $1.6M |
| LLYELI LILLY & Co | 665 | $612K |
| BMYBRISTOL MYERS SQUIBB CO | 8,538 | $518K |
| NVSNovartis AG | 2,335 | $357K |
| MCKMcKesson Corporation | 350 | $303K |
| ABTABBOTT LABORATORIES | 2,806 | $288K |
| ELVElevance Health Inc. | 688 | $201K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.